We plan to assess all patients with CNS tumors containing BCOR mutations. We owuld liek to study the differences amongst these patients including variety of tumor types, age at diagnosis, PFS/OS, and treatment regimens.
Get the Latest
news, articles, and resources sent to your inbox.